Anti-angiogenic therapy in ophthalmology [electronic resource] / Andreas Stahl, editor.
Stahl, Andreas, editor.
2016
RE48
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Anti-angiogenic therapy in ophthalmology [electronic resource] / Andreas Stahl, editor.
ISBN 9783319240978 (electronic book)
3319240978 (electronic book)
9783319240954
3319240951
Published Cham : Springer, 2016.
Language English
Description 1 online resource (x, 193 pages) : illustrations.
Call Number RE48
Dewey Decimal Classification 617.7/06
Summary This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.
Note Includes index.
Access Note Access limited to authorized users.
Source of Description Online resource; title from PDF title page (SpringerLink, viewed May 19, 2016).
Added Author Stahl, Andreas, editor.
Series Essentials in ophthalmology.
Available in Other Form Print version: 9783319240954
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Retinal Vascular Development
Retinopathy of Prematurity
Anti-Vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors
AREDS Supplementation and the Progression Towards Neovascular Exudative AMD
VEGF-Inhibition in Macular Telangiectasia Type 2
Diabetic Retinopathy
Retinal Vein Occlusion
Pharmacokinetics of Intravitreally Applied VEGF Inhibitors
Neovascular Glaucoma
Corneal Neovascular Diseases
Anti-Angiogenic Gene Therapy
Basic Science and Challenges for Translation into the Clinic.

Browse Subjects

Show more subjects...

Statistics

from
to
Export